Pilot Trial on the Effects of Propranolol on Gastrointestinal Symptoms in Autism Spectrum Disorder and Heart Rate Variability as a Treatment Response Biomarker [0.03%]
一项关于β受体阻滞剂普萘洛尔对自闭症患者胃肠症状影响的试点研究以及心率变异性的治疗反应生物标志物作用的研究
Bradley J Ferguson,Kristen Dovgan,Mackenzie Hoffman et al.
Bradley J Ferguson et al.
Background: Many individuals with autism spectrum disorder (ASD) experience gastrointestinal (GI) symptoms, which can impact social interactions, exacerbate social communication deficits, and decrease the quality of life. GI symptoms have b...
A Blueprint for Translational Precision Medicine in Autism Spectrum Disorder and Related Neurogenetic Syndromes [0.03%]
自闭症谱系障碍及相关神经遗传综合征的转化精准医疗蓝图
Robyn P Thom,Tracy L Warren,Suha Khan et al.
Robyn P Thom et al.
Objectives: Despite growing knowledge of the underlying neurobiology of autism spectrum disorder (ASD) and related neurogenetic syndromes, treatment discovery has remained elusive. In this review, we provide a blueprint for translational pr...
From the Editor-in-Chief's Desk: Special Issue on the Psychopharmacology of Neurodevelopmental Disorders [0.03%]
总编辑手记：神经发育障碍的精神药理学特刊
Paul E Croarkin
Paul E Croarkin
Pediatric Neuropsychiatric Syndromes: Updates on COVID-19 Infection and Vaccination [0.03%]
儿童神经精神综合征：COVID-19感染与疫苗接种的最新信息
Sarah O&#x;Dor,Celia Adams,Jessica Gavin et al.
Sarah O&#x;Dor et al.
Introduction: SARS-CoV-2 (COVID-19) infection has been implicated in the onset of neuropsychiatric symptoms in adults and children. While outcomes of COVID-19 infection and vaccination have been tracked in the general pediatric population, ...
Safety and Effectiveness of Clozapine in Youth and Young Adults with Neurodevelopmental Disorders and Severe, Treatment-Refractory Irritability and Aggression: A Retrospective Chart Review [0.03%]
神经发育障碍的青少年和年轻成人使用clozapine治疗严重且难以治愈的易怒和攻击行为的安全性和有效性：一项回顾性病历审查
Katherine Harris,Cara Fosdick,Katherine J Zappia et al.
Katherine Harris et al.
Objective: The purpose of this article was to review the safety, tolerability, and effectiveness of clozapine in youth and young adults with autism spectrum disorder (ASD) and/or intellectual disability. Methods: An IRB-approved retrospecti...
The Curious Case of Therapist Self-Disclosure During Pharmacotherapy Visits in an Autism Center [0.03%]
在自闭症治疗中心精神科医生在药物治疗过程中自我披露的奇怪案例研究
Sarah Daniella Kevelson
Sarah Daniella Kevelson
Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study [0.03%]
青年心理健康服务机构的药物处方模式：一项单中心回顾性横断面研究
Angela Dinh,Sarira El-Den,Jack C Collins et al.
Angela Dinh et al.
Objective: Rates of mental illness among young people remain elevated, and the utilization of youth mental health services is expected to increase. Yet, there is limited knowledge on real-world medication usage and prescribing at these serv...
Psychiatric Polygenic Risk Scores and Week-by-Week Symptomatic Status in Youth with Bipolar Disorder: An Exploratory Study [0.03%]
精神疾病多基因风险评分与双相情感障碍青少年的每周症状状态：一项探索性研究
Xinyue Jiang,Clement C Zai,John Merranko et al.
Xinyue Jiang et al.
Introduction: Prior studies have demonstrated that, in both adults and youth, bipolar disorder (BD) is a polygenic illness. However, no studies have examined polygenic risk scores (PRSs) in relation to the longitudinal course of mood sympto...
Treat to Sedation: Managing Intravenous Placement for Electroconvulsive Therapy in Autism with Intellectual Disability and Hyperactive Catatonia [0.03%]
镇静治疗：如何在自闭症、智力障碍和过度活跃的木僵状态中进行电休克疗法的静脉置管管理
Aparna Srinivasan,James Luccarelli,Rafael Tamargo et al.
Aparna Srinivasan et al.
Purpose: Catatonia is a severe psychomotor and mood-related disorder, which can significantly impact the quality of life for autistic individuals. Often, electroconvulsive therapy (ECT) is required for treatment of catatonia in autism. Howe...